Latest Videos |view all videos
An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of people with metastatic colorectal cancer, an international phase III clinical trial found.
Matthew K. Tollefson, M.D., provides patients and clinicians with a novel way to predict which cases of prostate cancer, the most commonly diagnosed malignancy in American men, will be aggressive and which ones can be safely monitored with watchful waiting.
Gerardo Colon-Otero, M.D., Desarrollos Recientes en Medicina de Cáncer Presentado el 25 de Septiembre, 2013 en la Clínica Mayo.
Abdirashid Shire, Ph.D. presents Hapatitis and Liver Cancer Among Somali Immigrants in Minnesota.
Robert B. Diasio, M.D., presents Overview of the Mayo Clinic Cancer Center.
Stephen N. Thibodeau, Ph.D., discusses Biorepositories and Biobanking in the Center for Individualized Medicine.
Fergus J. Couch, Ph.D., presents Breast Cancer Susceptibility.
Jerry D. Brewer, M.D., M.S., discusses his article, which noted increased survival rates for incidences of melanoma, in Olmsted County, Minnesota, demonstrating early-diagnosis effectiveness.
Richard W. Joseph, M.D., medical oncologist at Mayo Clinic's campus in Florida, talks about the most deadly form of skin cancer, known as melanoma.
S. Vincent Rajkumar, M.D., Mayo Clinic hematologist, discusses the first systematic study to determine association of monoclonal gammopathy of undetermined significance (MGUS) with all diseases in 17,398 patients, published in Mayo Clinic Proceedings.
Shernan Holtan, M.D., instructor in medicine and oncology at Mayo Clinic, discusses her November 2009 Mayo Clinic Proceedings article on the parallels between cancer and pregnancy, particularly in terms of immune modulation.
Dr. Gordon DeWald, professor emeritus in laboratory medicine and laboratory genetics at Mayo Clinic, provides an overview of his study on the use of fluorescence in situ hybridization (FISH).